Reply to: Do not discard Staphylococcus aureus WTA as a vaccine antigen

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Structure of S. aureus WTA and its variation by different GlcNAc transferases.


  1. 1.

    Gerlach, D. et al. Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 563, 705–709 (2018).

  2. 2.

    van Dalen, R. et al. Do not discard Staphylococcus aureus WTA as a vaccine antigen. Nature (2019).

  3. 3.

    Driguez, P. A. et al. Immunogenic compositions against S. aureus. WO patent WO/2017/064190 (2017).

  4. 4.

    Hütter, J. & Lepenies, B. Carbohydrate-based vaccines: an overview. Methods Mol. Biol. 1331, 1–10 (2015).

  5. 5.

    Rappuoli, R. Glycoconjugate vaccines: principles and mechanisms. Sci. Transl. Med. 10, eaat4615 (2018).

  6. 6.

    Kalka-Moll, W. M. et al. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169, 6149–6153 (2002).

  7. 7.

    Weidenmaier, C., McLoughlin, R. M. & Lee, J. C. The zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism. PLoS ONE 5, e13227 (2010).

  8. 8.

    Wanner, S. et al. Wall teichoic acids mediate increased virulence in Staphylococcus aureus. Nat. Microbiol. 2, 16257 (2017).

  9. 9.

    Brown, S. et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc. Natl Acad. Sci. USA 109, 18909–18914 (2012).

  10. 10.

    Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410 (1999).

  11. 11.

    Xia, G. et al. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J. Biol. Chem. 285, 13405–13415 (2010).

Download references


Our work was financed by grants from the German Research Foundation to A.P. (TRR34, CRC766, TRR156 and RTG1708) and T.S. (TRR34, CRC766) and the German Center for Infection Research and is supported by infrastructure provided by the Cluster of Excellence (EXC 2124).

Author information

D.G, Y.G., T.S. and A.P analysed data and wrote the manuscript.

Correspondence to Andreas Peschel.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.